632 studies found for:    "Urinary Bladder Neoplasms"
Show Display Options
Rank Status Study
1 Terminated Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer
Conditions: Urinary Bladder Diseases;   Urinary Bladder Neoplasms;   Urinary Bladder Cancer;   Malignant Tumor of Urinary Bladder;   Urologic Diseases;   Urologic Neoplasms;   Neoplasms;   Neoplasms by Site
Interventions: Device: Synergo + MMC;   Drug: Bacillus Calmette-Guérin
2 Recruiting Evaluation of Non-Invasive Assay(s) for the Detection of Bladder Cancer
Conditions: Bladder Cancer;   Cancer;   Bladder Neoplasms;   Urinary Bladder Cancer
Intervention:
3 Recruiting Chemoradiation for Bladder Preservation in Patients With Muscle Invasive Bladder Carcinoma After Complete Response to Neoadjuvant Chemotherapy
Conditions: Bladder Cancer;   Bladder Carcinoma;   Transition Cell Cancer;   Muscle Invasive Bladder Carcinoma
Interventions: Procedure: Transurethral Resection of the Bladder Tumor & Cystoscopy;   Drug: Cisplatin;   Drug: Gemcitabine;   Radiation: Intensity Modulated Radiation Therapy;   Behavioral: Quality of Life Questionnaires;   Genetic: Urine Collection for Molecular Analysis;   Genetic: Blood Collection for Molecular Analysis
4 Recruiting Irreversible Electroporation(IRE) For Unresectable Urinary Bladder Neoplasms
Condition: Urinary Bladder Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
5 Active, not recruiting Molecular Analysis Of Bladder Cancer
Conditions: Bladder Cancer;   Bladder Neoplasms
Intervention:
6 Completed
Has Results
Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder
Conditions: Carcinoma, Transitional Cell;   Bladder Cancer;   Bladder Neoplasm
Interventions: Drug: Pralatrexate Injection;   Dietary Supplement: Vitamin B12;   Dietary Supplement: Folic Acid
7 Active, not recruiting Safety and Efficacy Study of Cancer Immunotherapeutic MAGE-A3 + AS-15 in Patients With Muscle-invasive Bladder Cancer After Cystectomy
Condition: Urinary Bladder Neoplasms
Interventions: Biological: recMAGE-A3 + AS15 ASCI;   Biological: Placebo
8 Terminated A Phase 0 of Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before Cystectomy
Conditions: Bladder Carcinoma;   Infiltrative Bladder Carcinoma;   Cystectomy
Intervention: Drug: LAPATINIB
9 Recruiting Adjuvant Radiation for High Risk Bladder Cancer
Conditions: Bladder Cancer;   Squamous Cell Carcinoma of the Bladder;   Stage III Bladder Cancer;   Stage IV Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Interventions: Radiation: 3D conformal radiation therapy;   Procedure: quality-of-life assessment;   Procedure: therapeutic conventional surgery
10 Unknown  Prostate Capsule Sparing Cystectomy and Nerve-sparing Radical Cystoprostatectomy in Men With Bladder Cancer
Conditions: Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Interventions: Procedure: Prostate capsule sparing cystectomy;   Procedure: Nerve sparing cystectomy
11 Completed Gene Therapy in Treating Patients With Advanced Bladder Cancer
Conditions: Recurrent Bladder Cancer;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Stage IV Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Intervention: Biological: Ad5CMV-p53 gene
12 Completed Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer
Condition: Urinary Bladder Neoplasm
Interventions: Drug: Mitomycin C;   Drug: BCG
13 Active, not recruiting Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery
Conditions: Recurrent Bladder Cancer;   Stage 0 Bladder Cancer;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Interventions: Drug: broccoli sprout extract;   Other: laboratory biomarker analysis
14 Terminated Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy
Conditions: Bladder Adenocarcinoma;   Bladder Squamous Cell Carcinoma;   Bladder Urothelial Carcinoma;   Recurrent Bladder Carcinoma;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Stage IV Bladder Cancer
Interventions: Biological: Recombinant Fowlpox-TRICOM Vaccine;   Biological: Recombinant Fowlpox GM-CSF Vaccine Adjuvant;   Procedure: Therapeutic Conventional Surgery;   Other: Pharmacological Study;   Other: Laboratory Biomarker Analysis
15 Recruiting Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery
Conditions: Recurrent Bladder Carcinoma;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer
Interventions: Drug: Erlotinib Hydrochloride;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Other: Placebo;   Procedure: Therapeutic Conventional Surgery
16 Recruiting Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer
Conditions: Recurrent Bladder Carcinoma;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Stage IV Bladder Cancer
Interventions: Drug: Sirolimus;   Drug: Cisplatin;   Drug: Gemcitabine Hydrochloride;   Procedure: Therapeutic Conventional Surgery;   Other: Laboratory Biomarker Analysis
17 Active, not recruiting Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer
Conditions: Distal Urethral Cancer;   Proximal Urethral Cancer;   Squamous Cell Carcinoma of the Bladder;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Urethral Cancer Associated With Invasive Bladder Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: cisplatin;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis
18 Unknown  Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Other: questionnaire administration;   Procedure: quality-of-life assessment;   Procedure: robot-assisted laparoscopic surgery;   Procedure: therapeutic conventional surgery;   Procedure: therapeutic laparoscopic surgery
19 Active, not recruiting A Study of MPDL3280A in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Condition: Carcinoma, Transitional Cell , Bladder Cancer, Bladder Tumors, Urinary Bladder Neoplasms
Intervention: Drug: MPDL3280A
20 Completed Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
Conditions: Bladder Urothelial Carcinoma;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer
Interventions: Drug: Paclitaxel;   Biological: Trastuzumab;   Radiation: Radiation Therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years